Martin Kulldorff, who was chair of the panel that advises the Centers for Disease Control and Prevention, is joining the Department of Health and Human Services (HHS) to advise Health Secretary Robert F. Kennedy Jr., officials announced on Dec. 1.
Kulldorff was appointed chief science officer of the HHS Office of the Assistant Secretary for Planning and Evaluation, HHS said. The office is the department’s think tank and provides policy advice to the secretary of health.
Earlier in the year, Kennedy removed all members from the Advisory Committee on Immunization Practices (ACIP), which advises the CDC on vaccines, and appointed Kulldorff and other new members to the committee.
Kulldorff said in a statement that he was honored to join other scientists Kennedy has hired.
“I look forward to contributing to the science-based public health policies that will Make America Healthy Again,” he stated.
Kulldorff, who holds a doctorate in operations research, was a professor at Harvard Medical School when the COVID-19 pandemic started. Kulldorff, who had constructed drug and vaccine safety monitoring systems, also advised the CDC at the time on vaccine safety.
Kulldorff also coauthored the Great Barrington Declaration, which urged officials to reverse the forced closures of businesses and schools in favor of more limited restrictions that mainly targeted at-risk groups, such as the elderly.
Kulldorff’s exit from ACIP comes days before the panel’s next meeting. Panelists are scheduled to discuss the childhood vaccine schedule and hepatitis B vaccination.
Dr. Kirk Milhoan, a pediatric cardiologist, has been named as the panel’s new chair, HHS said. Dr. Robert Malone, a professor at Louisiana State University’s Pennington Biomedical Research Center, is still the panel’s vice chair.
Milhoan told The Epoch Times that people can expect the panel, under his leadership, to engage in “a continued look at true risk-benefit analysis of any intervention” it recommends, including working to compel scientific studies done on subjects for which there is not adequate data.







